PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Geilenkeuser, J. ; Armbrust, N. ; Steinmaßl, E. ; Du, S.W.* ; Schmidt, S. ; Binder, E.M.H. ; Li, Y. ; Warsing, N.W. ; Wendel, S.V. ; von der Linde, F. ; Schiele, E.M. ; Niu, X. ; Stroppel, L. ; Berezin, O. ; Santl, T. ; Orschmann, T. ; Nelson, K. ; Gruber, C. ; Palczewska, G.* ; Menezes, C.R.* ; Risaliti, E.* ; Engfer, Z.J.* ; Koleci, N.* ; Schmidts, A.* ; Geerlof, A. ; Palczewski, K.* ; Westmeyer, G.G. ; Truong, D.J.J.

Engineered nucleocytosolic vehicles for loading of programmable editors.

Cell 188:51 (2025)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Advanced gene editing methods have accelerated biomedical discovery and hold great therapeutic promise, but safe and efficient delivery of gene editors remains challenging. In this study, we present a virus-like particle (VLP) system featuring nucleocytosolic shuttling vehicles that retrieve pre-assembled Cas-effectors via aptamer-tagged guide RNAs. This approach ensures preferential loading of fully assembled editor ribonucleoproteins (RNPs) and enhances the efficacy of prime editing, base editing, trans-activators, and nuclease activity coupled to homology-directed repair in multiple immortalized, primary, stem cell, and stem-cell-derived cell types. We also achieve additional protection of inherently unstable prime editing guide RNAs (pegRNAs) by shielding the 3'-exposed end with Csy4/Cas6f, further enhancing editing performance. Furthermore, we identify a minimal set of packaging and budding modules that can serve as a platform for bottom-up engineering of enveloped delivery vehicles. Notably, our system demonstrates superior per-VLP editing efficiency in primary T lymphocytes and two mouse models of inherited retinal disease, highlighting its therapeutic potential.
Impact Factor
Scopus SNIP
Altmetric
42.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Vlps ; Base Editing ; Cell Therapy ; Gene Delivery ; Gene Therapy ; Genome Editing ; In Vivo Delivery ; Prime Editing ; Virus-like Particles; Genomic Dna; Target Base; Stem-cells; Protein; Rna; Domain
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0092-8674
e-ISSN 1097-4172
Zeitschrift Cell
Quellenangaben Band: 188, Heft: 10, Seiten: , Artikelnummer: 51 Supplement: ,
Verlag Cell Press
Verlagsort Cambridge, Mass.
Begutachtungsstatus Peer reviewed
Institut(e) Insitute of Synthetic Biomedicine (ISBM)
Institute of Developmental Genetics (IDG)
Institute of Structural Biology (STB)
POF Topic(s) 30205 - Bioengineering and Digital Health
30204 - Cell Programming and Repair
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
Genetics and Epidemiology
PSP-Element(e) G-509300-001
G-500500-001
G-503000-001
Förderungen University of California, Irvine School of Medicine Dean's Office grant
Free State of Bavaria within the framework of the Excellence Strategy of the Federal Government
Lander through the ONE MUNICH project Munich Multiscale Biofabrication
European Research Council
European Innovation Council
National Institutes of Health (NIH)
Department of Ophthalmology, Gavin Herbert Eye Institute at the University of California, Irvine
Research to Prevent Blindness award
NIH
German Federal Ministry of Education and Research (BMBF)
DOI 10.1016/j.cell.2025.03.015
WOS ID 001494695200005
Scopus ID 105002259397
PubMed ID 40209705
Erfassungsdatum 2025-05-10
[➜Korrektur melden]